Učitavanje...
Application of Ventana immunocytochemical analysis on ThinPrep cytology slides for detection of ALK rearrangement in patients with advanced non–small-cell lung cancer
Abstract Background Ventana ALK (D5F3) screening of anaplastic lymphoma kinase (ALK) gene rearrangement in tissue specimens has been approved by US FDA (Food and Drug Administration) to select treatment for non–small-cell lung carcinoma (NSCLC). However, tumor tissues are often not readily obtainabl...
Spremljeno u:
Glavni autori: | , , , , , , , , , |
---|---|
Format: | Artigo |
Jezik: | Inglês |
Izdano: |
BMC
2018-12-01
|
Serija: | BMC Cancer |
Teme: | |
Online pristup: | http://link.springer.com/article/10.1186/s12885-018-5184-x |
Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|